Description
fMLFK is a peptide that binds n-formyl peptide receptors (FPRs) on neutrophils, playing a role in neutrophil activation.
| Product Unit Size | Cost | Quantity | Stock |
|---|
fMLFK is a peptide that binds n-formyl peptide receptors (FPRs) on neutrophils, playing a role in neutrophil activation.
| Cas No. | 104180-18-9 |
|---|---|
| Purity | ≥95% |
| Formula | C27H43N3O5S |
| Formula Wt. | 565.74 |
| Synonym | Chemotactic peptide, N-Formyl-Met-Leu-Phe-Lys |
| Appearance | White to off white powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
He HQ, Troksa EL, Caltabiano G, et al. Structural determinants for the interaction of formyl Peptide receptor 2 with Peptide ligands. J Biol Chem. 2014 Jan 24;289(4):2295-306. PMID: 24285541.
AR antagonist.
Mycotoxin contaminant in food and feed.
Mycotoxin produced by species of Aspergillus; D...
Hydroxypyridone, metal ion chelator; mTOR inhib...
Immunomodulator; teratogen.
Steroidal saponin found in Dioscorea.
JAK2 inhibitor.
CB1 agonist, TRPV1 agonist.
Morpholine derivative.
mAChR agonist, selective for M2.
CHK1 inhibitor.
mTOR activator.
Endogenous prostaglandin, vasodilator.
CDK4/6 inhibitor.
Fluoroquinolone; topoisomerase IV and bacterial...
Endogenous tachykinin peptide, involved in infl...
Resveratrol prodrug; potential SIRT1 activator....
Endogenous peptide neurotransmitter, involved i...
DNA alkylator.
4-Hydroxytamoxifen prodrug; FIASMA, SERM, PKC i...